Skip to main content

ABIRAPRO 250MG TABLET (Abiraterone acetate) |Apple pharmaceuticals

ABIRAPRO 250MG

          Abirapro 250mg is belongs to type of anti-cancer medication that will act by decline the androgen production in the body. Androgen is a male hormone that canmaintance the tumor cell in prostate glands, the main ingredient which is used as abiraterone . Actually thisdrug is given by co administration with prednisolone, a steroid which reduce the liability of side effects produced by Abiraterone.

MECHANISM OF ACTION

          Androgens are balance the production of malignant in prostate. Abiraprois belongs to anti androgen drugs, thatcauses to suppress the enzyme 17α-hydroxylase C 17, 20-lyase (CYP17), it is involves in androgen conglomerate. Reduce the serum testosterone level. Declined the tumor cell occurred.

SAFETY AND WARNING OF ABIRAPRO
    
        Anyallergy, serious liver problem or pregnant in patient, Abiraprotherapy should be stopped Avoid taking of other medications, i.e prescription, over-the-counter, vitamins, herbal remedies, etc be sure to inform the doctors before the treatment. Do not take Aspirin administrated and products containing aspirin till doctor particularly allow the drug.
abirapro 250mg tablet
abirapro 250mg tablet

PHARMACOKINETICS

Absorption:   Time to maximum plasma concentration of Abiraprotablet takes 12 hours.
Distribution:  Maximum bound to the human plasma protein like albumin and alpha-1 acid                                        glycoprotein.
Metabolism:   Themain two metabolites of Abiraterone in human plasma are Abiraterone sulphate                               and N-oxide Abiraterone sulphate.
Excretion:      The drug mainly excreted in 88% feces and 5% in urine Half-life of tablet Abirapro is                          12 ± 5 hours.

DRUG INTERACTION

          Interaction of Abirapro with dextromethorphan will raises the Cmax and AUC of dextromethorphan Interaction Abirapro with strong CYP3A inhibitors or inducers , concomitant use with caution because pharmacokinetics is not evaluated.

PREGNANCY

         Pregnancy category X: while ontherapy with Abirapro tablet if women become pregnant, immediately stop the drug and give counseling to the women. Abirapro tablet is not recommended for women.

STORAGE

        The drug stored at 15℃ - 30℃. Keep the drug in dry place.

MISSED DOSE

         If patient missed the dose of Abirapro 250mg, that missed dose will be skipped and follow the regular dosing schedule.
abirapro 250mg tablet
abirapro 250mg tablet

SIDE EFFECTS

          Common effects Fatigue, Arthralgia, Hypertension, Nausea, edema, Hypokalemia, Diarrhea, vomiting, Cough, headache, Glucocorticoid deficiency,Mineral corticoid deficiency, Hepatotoxicity, Hypertension, Decrease in ka level, Adrenocortical insufficiency Musculo skeletal and Connective tissue disorders:Joint swelling, discomfort, muscle discomfort General Disorder:Oedema Cardiac disorders:Hot flush, hypertension, arrhythmias, chest pain, cardiac failure GIT disorders:Diarrhea, dyspepsia Infections and Infestation:UTI Pulmonary disorder:Cough Renal:Urinary frequency, nocturia Injuries:Fractures

OVERDOSAGE

          Abirapro has no essential antidote, If overdose occurs end treatment with the drug and give general supportive measures such as monitoring arrhythmias and cardiac failure and assess liver function.

Phone Number

+91-9987711567

URL

Email ID

applepharmaceutical@gmail.com
info@myapplepharma.com

Labels:

Comments

Post a Comment

Popular posts from this blog

Comprar Tagrisso 80mg | Precio Tagrisso 80mg medicina

DESCRIPCIÓN Una tableta de Tagrisso de 80 mg contiene un principio activo conocido como Osimeritinib, que antes se conocía como Mereletinib.Tagrisso 80 mg está considerado como medicamento de tercera generación, que está disponible en forma de tableta.Tagrisso 80 mg es un inhibidor inevitable del receptor del factor de crecimiento epidérmico, desviado de manera selectiva, que contiene actividad anticancerígena. La categoría farmacológica de Tagrisso 80mg es tirosina quinasa prohibitor. INDICACIÓN Un comprimido de Tagrisso 80 mg (osimertinib) está ampliamente indicado como tratamiento de primera línea para el cáncer de pulmón no microcítico avanzado con pacientes con mutación EGFR positiva.Tagrisso 40mgi s también se utiliza para el tratamiento de pacientes afectados con una mutación positiva de EGFR T792M NSCLC, la enfermedad ha avanzado en o después del tratamiento con inhibidores de la tirosina quinasa.Usos en Embarazo, lactancia, pediatría: No se asigna la categoría de embara...
Post a Comment
Read more

IKGDAR 500MG INJECTION | Rituximab | Apple Pharmaceuticals

Ikgdar 500mg Ikgdar 500mg is a anticancer medicine which prevents the growth and spread of cancer cells in the body, the main ingredient which is used as rituximab . Ikgdar 500mg will help to prevent the Non- Hodgkin’s lymphoma or chronic lymphocytic and with combination with another anticancer drugs like methotrexate is used for rheumatoid arthritis symptoms in adult treatment. Ikgdar 500mg with steroid regimen combination is given for the treatment of some rare disorders which cause blood vessels and other tissues inflammation in the body. INDICATIONS Ikgdar 500mg and hyaluronidase human injection are given alone or combination with another drugs to treat certain types of non-Hodgkin's lymphoma and chronic lymphocytic leukemia (cancer start in WBC). Ikgdar 500mg injection combination with methotrexate (Otrexup, Rasuvo, Xatmep, others) is also indicated for the treatment rheumatoid arthritis symptoms in adults that have been already treated with a some type of regimen kno...
Post a Comment
Read more

Comprar Sorafenat | Precio Sorafenat medicina

DESCRIPCIÓN Sorafenat pertenece a una clase de inhibidores de múltiples quinasas, el ingrediente principal que se utiliza como sorafenib . No se usa como medicamento curable, pero Sorafenat se usa para reducir la tasa de crecimiento de las células cancerosas mediante la barrera. Las acciones de una transducción de señales de proteínas anormales ayudan a desarrollar las células cancerosas. El sorafenat es un mecanismo que agota el suministro de sangre a las células cancerosas y estopa su división y producción. INDICACIONES Sorafenat está indicado para el tratamiento en pacientes con carcinoma hepatocelular. Y para el tratamiento del cáncer de riñón se utiliza la tableta de Sorafenat . Sorafenat está indicado para el tratamiento de pacientes con carcinoma avanzado refractario al yodo radioactivo (cáncer de tiroides metastásico). FARMACOLOGÍA Sorafenat suprime la superficie de la célula y la quinasa intracelular para retrasar el desarrollo de células tumorales. Sorafenat funcio...
Post a Comment
Read more